PHILADELPHIA, April 26, 2017 /PRNewswire/ -- Aberdeen
Singapore Fund, Inc. (the "Fund") (NYSE: SGF), a closed-end
equity fund, announced today its performance data and portfolio
composition as of March 31, 2017.
The Fund's total returns for various periods through
March 31, 2017 are provided
below. (All figures are based on distributions reinvested at
the dividend reinvestment price and are stated net-of-fees):
|
Cumulative as of
03/31/17
|
Annualized as of
03/31/17
|
|
1
Month
|
3
Month
|
YTD
|
1
Year
|
3
Years
|
5
Years
|
10
Years
|
Since
Inception
|
NAV
|
3.4
|
15.9
|
15.9
|
13.4
|
0.5
|
2.9
|
2.4
|
5.0
|
Market
Price
|
10.3
|
24.7
|
24.7
|
20.6
|
0.8
|
2.5
|
2.2
|
4.3
|
MSCI
Singapore
|
2.2
|
13.5
|
13.5
|
9.6
|
-0.5
|
1.8
|
3.4
|
6.1
|
On March 31, 2017, the Fund's net
assets amounted to US$89.6 million
and the Fund's NAV per share was US$12.08.
As of March 31, 2017, the
portfolio was invested as follows:
Portfolio
Composition
|
Percent of
Net Assets
|
Financials
|
29.3
|
Real
Estate
|
25.1
|
Industrials
|
23.4
|
Telecommunications
|
7.4
|
Information
Technology
|
4.0
|
Health
Care
|
3.7
|
Consumer
Discretionary
|
3.5
|
Consumer
Staples
|
1.9
|
Materials
|
0.3
|
Cash
|
1.5
|
The Fund's ten largest equity holdings as of March 31, 2017, representing 62.6% of net assets,
were:
Stock
|
Percent
of
Net
Assets
|
Oversea-Chinese
Banking Corporation
|
10.5
|
DBS Group
Holdings
|
8.4
|
Singapore
Telecom
|
7.4
|
City
Developments
|
7.2
|
United Overseas
Bank
|
6.8
|
Jardine
Matheson
|
6.0
|
Keppel
Corporation
|
5.2
|
Singapore
Technologies Engineering
|
3.8
|
Raffles Medical
Group
|
3.7
|
Venture
Corporation
|
3.6
|
Important Information
Aberdeen Asset Management Inc. has prepared this report based on
information sources believed to be accurate and reliable.
However, the figures are unaudited and neither the Fund, Aberdeen
Asset Management Inc. (the Administrator), Aberdeen Asset
Management Asia Limited (the Investment Manager), nor any other
person guarantees their accuracy. Investors should seek their
own professional advice and should consider the investment
objectives, risks, charges and expenses before acting on this
information. The Investment Manager and Administrator are each a
wholly owned subsidiary of Aberdeen Asset Management PLC.
Aberdeen Asset Management PLC announced on March 6, 2017 that it entered into an agreement
with Standard Life plc to carry out an all-share merger, subject to
regulatory and other approvals. More information about the
potential merger can be found on Aberdeen's website at
www.aberdeen-asset.com. Aberdeen is a U.S. registered service mark
of Aberdeen Asset Management PLC.
Closed-end funds are traded on the secondary market through one
of the stock exchanges. The Fund's investment return and principal
value will fluctuate so that an investor's shares may be worth more
or less than the original cost. Shares of closed-end funds may
trade above (a premium) or below (a discount) the net asset value
(NAV) of the fund's portfolio. There is no assurance that the Fund
will achieve its investment objective.
Total return figures with distributions reinvested at the
dividend reinvestment price are stated net-of-fees and represents
past performance. Past performance is not indicative of
future results, current performance may be higher or lower.
Holdings are subject to change and are provided for informational
purposes only and should not be deemed as a recommendation to buy
or sell the securities shown. Inception date July 31, 1990.
If you wish to receive this information electronically, please
contact: InvestorRelations@aberdeen-asset.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/aberdeen-singapore-fund-inc-announces-performance-data-and-portfolio-composition-300446631.html
SOURCE Aberdeen Singapore Fund, Inc.